Do you need a Washington, DC Medtronic Defibrillator Lead lawyer? Contact one of our Washington, DC Medtronic Defibrillator Lead lawyers now.
Home : Medical Devices : Medtronic Defibrillator Lead : News Articles
Medtronic Defibrillator Lead - News Articles
-
but because of costly problems that Medtronic experienced with two of its products: the Fidelis lead (a wire that connects an implantable defibrillator to the heart muscle) and the Infuse bone graft product (a bone-filling material that contains a bone protein). Plaintiffs ... -
On 03/17/10, Medtronic, Inc. (NYSE:MDT) announced the commercial availability of the Advisa DR MRI™ SureScan™ pacemaker in selected European geographies. ... -
Medical-technology company Medtronic Inc. (MDT) on Wednesday said it has received US Food and Drug Administration approval for the MiniMed Paradigm ... -
Specifically, women were less likely than men to receive an implantable cardioverter defibrillator (ICD) when indicated (43.2 percent vs. 53.7 percent), education about their condition (59.2 percent vs. 62.4 percent), or ... -
St. Jude Medical Inc. and Medtronic Inc., which sell competing defibrillators, are likely to benefit from the recall because doctors will still need devices ... -
Medtronic: Wedbush discusses potential windfall from BSX announcement . Wedbush notes Medtronic shareholders are giddy today over the co's potential ... -
Medtronic (MDT) , a medical device maker, fell 1.5% after the FDA said the company's study on its Revo Surescan pacemaker suffered from a small population size and missing data. var articlePage = 1; ... -
Dean, who has consulting ties to Medtronic. He spoke on the sidelines of the American College of Cardiology's annual conference here. ... -
St. Jude Medical Inc. and Medtronic Inc., which sell competing defibrillators, are likely to benefit from the recall because doctors will still need devices ... -
to lead users to additional information, AdvaMed and Medtronic say in comments on the use of social media to communicate about medical products. ...
-
Yields on high quality corporate bonds are extremely low, like 4.25% for a Medtronic with about a 10 year time horizon and so forth. The yields on many stocks are higher and they have the other advantages listed above. Beyond simple ... -
They also said Medtronic should track patient safety for five years The FDA is not required to follow the panel's advice, though it usually does. ... -
The FDA will consider the recommendation. The agency usually approves products backed by advisory panels. Wider FDA approval could help Medtronic expand sales of the device. The product is part of the company's neuromodulation business, which made up about $1.4 billion ... -
Dr. Van Meirhaeghe or a member of his immediate family received something of value from or owns stock (or stock options) from Medtronic, a commercial company related to the research indicated in this abstract. ... -
The FDA is already urging popular manufacturers of these pumps – including Johnson & Johnson, Roche and Medtronic, Inc. – to create warnings and directions that help educate the consumers properly. According to the FDA, more than 375,000 people with type-1 diabetes ... -
Take Medtronic's Innervision Snap Shunt Ventricular Catheter that the company voluntary recalled in February 2009 and which the FDA categorized as a Class I recall a month later in March. The catheter is used to drain excess fluid buildup in the brain, ... -
Medtronic Inc., Amgen Inc. and Anadarko Petroleum Co. also issued 30-year debt this week, Bloomberg data show. “We've seen more 30-year transactions than one would otherwise expect,” said Peter Aherne, head of North America capital markets at Citigroup Inc. Companies are issuing ... -
The committee will discuss, make recommendations, and vote on use of Medtronic Inc's Deep Brain Stimulation (DBS) Therapy for as an adjunctive therapy for reducing the frequency of seizures in individuals diagnosed with epilepsy. The device is already approved for use in patients ... -
A former device saleswoman who brought those two cases has also sued Boston Scientific, Medtronic and St. Jude Medical. The DOJ hasn't joined in those cases and the companies say none of their top execs were involved in any illegal marketing of the devices. More ... -
Since 2008, there have been at least five US patient deaths reported to an FDA data base in procedures using AtriCure devices and one involving a Medtronic ...
Do you need a Washington, DC Medtronic Defibrillator Lead lawyer? Contact one of our Washington, DC Medtronic Defibrillator Lead lawyers now.
Pages: 1 2 3 4 5 6 ... Next
